[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 6 sources · 7 days · First seen · Last updated

South Korean biohealth global market expansion

Overview

South Korean biohealth and healthcare companies are engaging in international trade and investment consultations to expand their global presence.

In late September 2026, Busan Metropolitan City hosted a joint pavilion for ten local medical device and healthcare companies at Medical Fair Asia in Singapore. The initiative facilitated 190 consultations with a total value of approximately 6.8 billion won ($4.9 million), including 110 million won in immediate on-site contracts. Busan officials also engaged in networking events and discussions regarding the strengthening of regional biohealth clusters.

By early October 2026, Incheon-based bio-healthcare startups expanded their outreach to the United States. Through the ‘RESI Boston 2026’ event, six participating firms conducted approximately 60 business consultations totaling $90 million in potential scale. These discussions with major global entities focused on technologies such as AI-based medical software, gene-editing, and next-generation antibiotics.

Entities

Bugi Tech Investment Show · Incheon Startup Park · RESI Boston · KOTRA · Bodyfriend

Timeline

  1. [BUSINESS] 2 sources
    Incheon bio-healthcare startups conduct $90 million in US investment consultations

    Six Incheon-based bio-healthcare startups conducted $90 million in business consultations during the RESI Boston 2026 investment event in the United States.

  2. [BUSINESS] 3 sources
    Busan biohealth firms secure 6.8 billion won in consultations at Singapore expo

    Busan Metropolitan City's biohealth pavilion at Medical Fair Asia 2026 recorded 6.8 billion won in consultations and expanded market access for local medical device firms in Southeast Asia.

Sources

biz.heraldcorp.com · cunews.net · localsegye.co.kr · seoul.co.kr · venturesquare.net · zdnet.co.kr